West Virginia University Logo

December 12, 2012

SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv

Return to Listserv Archive Home

December 12, 2012 (PDF version)
 
Feature Article of Importance

Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings
Substance Abuse and Mental Health Services Administration
2012

Fewer people (4.5 million) age 12 and older used pain relievers for a nonmedical purpose in 2011 than in 2010 (5.1 million) and 2009 (5.3 million). Among the groups in 2010-11 that used pain relievers nonmedically in the past 12 months, 54.2 percent got their drugs from a friend or relative.

Read more:
http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.pdf


Journal Articles and Major Reports

G. Caleb Alexander, Stefan P. Kruszewski, and Daniel W. Webster. 2012. "Rethinking Opioid Prescribing to Protect Patient Safety and Public Health." Journal of the American Medical Association 308(18):1865-66. doi:10.1001/jama.2012.14282.

Researchers found correlations among national trends for prescription opioid sales, admissions for substance abuse treatment, and overdose deaths. They recommended complementing regulatory and enforcement measures to prevent nonmedical use and diversion with changes to clinical guidelines for treating chronic pain that are less reliant on opioids.

Read more:
http://jama.jamanetwork.com/article.aspx?articleid=1391927 
Related Article
Overprescribing of Opioids Impacts Patient Safety and Public Health
HealthCanal.com
December 3, 2012

According to Health Canal, a viewpoint article published in the Journal of the American Medical Association suggests the clinical practice of prescribing amphetamines, opioids, and benzodiazepines for chronic pain may be contributing to the increase in fatal drug overdoses and the likelihood that these drugs will be diverted to the illegal market.

Read more:
http://www.healthcanal.com/public-health-safety/34470-Overprescribing-Opioids-Impacts-Patient-Safety-and-Public-Health.html

H. Gugelmann and L. Nelson. 2012. "The Prescription Opioid Epidemic: Repercussions on Pediatric Emergency Medicine." Clinical Pediatric Emergency Medicine 13(4):260-68.

This article discusses young children's increased susceptibility to adverse effects of prescription opioids and neonatal abstinence syndrome. Researchers suggest a multifaceted approach to contain the problem.

Read more:
http://www.clinpedemergencymed.com/article/S1522-8401(12)00081-X/abstract


B.C. Kelly, B.E. Wells, A. Leclair, D. Tracy, J.T. Parsons, and S.A. Golub. 2012. "Prescription Drug Misuse Among Young Adults: Looking Across Youth Cultures." Drug and Alcohol Review. doi:10.1111/dar.12016.

According to researchers, the fluctuating prevalence of prescription drug misuse across distinct youth cultures suggests the trend has not diffused equally among young people.

Read more:
http://www.ncbi.nlm.nih.gov/pubmed/23190213


Kathleen R. Merikangas, Jian-ping He, Judith Rapoport, Benedetto Vitiello, and Mark Olfson. 2012. "Medication Use in U.S. Youth With Mental Disorders." Archives of Pediatric and Adolescent Medicine. doi:10.1001/jamapediatrics.2013.431.

Researchers did not find compelling evidence for misuse or overuse of psychotropic medications. The data emphasizes a need for greater recognition of and appropriate treatment for youths with mental health disorders.

Read more:
http://archpedi.jamanetwork.com/article.aspx?articleid=1465762
 
Related Article
Study Examines Psychotropic Medication Use Among U.S. Adolescents With Mental Disorders
Medical Xpress
December 3, 2012

A survey found 14.2 percent of 13- to 18-year-old adolescents with a mental health disorder reported being treated with a psychotropic medication in the last 12 months, which researchers suggest challenges concerns about widespread overmedication and psychotropic medication misuse among young people.

Read more:
http://medicalxpress.com/news/2012-12-psychotropic-medication-adolescents-mental-disorders.html

News and Reports

Law Enforcement Alerted to Possible Influx of Painkillers From Canada
The Partnership at Drugfree.org
December 5, 2012

Unless the Food and Drug Administration takes action, generic versions of the no-longer-marketed crushable painkillers OxyContin and Opana may return to the market within months. Generic Opana would become legal on Jan. 1, and generic OxyContin in spring. Canada has a worse problem. The Canadian Health Ministry has approved generic copies of OxyContin but is under political pressure to rescind the approval. The White House Office of National Drug Control Policy has alerted law enforcement agencies nationwide to prepare for the influx of OxyContin's generic version from Canada. The alert says, "The potential exists for diversion into the United States because the old formulations, which are easier to abuse, are unavailable in the United States."

Read more:
http://www.drugfree.org/join-together/prescription-drugs/law-enforcement-alerted-to-possible-influx-of-painkillers-from-canada
http://americannewsreport.com/u-s-fears-flood-of-generic-canadian-oxycodone-8817027


Pain Management and Opioid Abuse: A Public Health Concern
American Academy of Family Physicians
2012

This position paper's recommendations are grouped into four categories: advocacy, clinical, continuing education for family physicians, and collaboration with others. It suggests states should obtain physicians' input when considering pain management regulation and legislation and supporting development of evidence-based physician education.

Read more:
http://www.aafp.org/online/etc/medialib/aafp_org/documents/clinical/painmanagement/painmanagementopioids.Par.0001.File.dat/Opioid%20Abuse%20Position%20Paper%20FINAL.pdf
Related Article
AAFP Outlines Strategies for Combating, Curtailing Prescription Drug Abuse
PharmPro.com
December 5, 2012

The article discusses the American Academy of Family Physicians' decision to give members educational tools and resources for curtailing and preventing nonprescription opioid use. The organization issued a position paper on pain management and opioid abuse that makes eight overarching recommendations.

Read more:
http://www.pharmpro.com/News/Feeds/2012/12/agencies-and-organizations-aafp-outlines-strategies-for-combating-curtailing

2012 Arizona Youth Survey
Arizona Criminal Justice Commission
2012

This report summarizes findings from the Arizona Youth Survey, which was administered to students in the 8th, 10th, and 12th grades in spring 2012. The rate of students who had used prescription drugs in the past 30 days declined from 10 percent in 2010 to 8 percent in 2012. In 2010, 67 percent of students acquired prescription drugs from their friends--a rate that dropped to 58 percent in 2012.

Read more:
http://www.azcjc.gov/ACJC.Web/Pubs/Home/2012%20Arizona%20Youth%20Survey%20Profile%20Report.pdf
Related Article
New Survey Shows Decrease in Youth Drug and Alcohol Abuse
Eastern Arizona Courier
December 1, 2012

This article discusses the Arizona Criminal Justice Commission's 2012 Youth Survey, which shows a decrease in the number of teens drinking alcohol, smoking marijuana, and abusing prescription drugs.

Read more:
http://www.eacourier.com/news/new-survey-shows-decrease-in-youth-drug-and-alcohol-abuse/article_cefb06a8-3b71-11e2-8061-001a4bcf887a.html

What Does Rising Prescription Drug Abuse Mean for the War on Drugs?
Houston Chronicle
December 3, 2012

The Baker Institute Blog post presents Gary Hale's perspective on the prescription drug problem. Hale is the former Chief of Intelligence for the Drug Enforcement Administration's Houston Field Division.

Read more:
http://blog.chron.com/bakerblog/2012/12/what-does-rising-prescription-drug-abuse-mean-for-the-war-on-drugs


Drug of Focus Is at Center of Suspensions
The New York Times
December 1, 2012

Use and abuse of Adderall--a prescription drug that controls attention deficit hyperactivity disorder--is a major problem for the National Football League this season.

Read more:
http://www.nytimes.com/2012/12/02/sports/football/adderall-a-drug-of-increased-focus-for-nfl-players.html?pagewanted=all&_r=0


Practice Safe Rx
The Huffington Post
December 3, 2012

The author writes about problems with compounding pharmacies, online drug purchasing, and talking to doctors and pharmacists about prescription drugs.

Read more:
http://www.huffingtonpost.com/glenn-d-braunstein-md/prescription-drug-safety_b_2219798.html


Unused Pills Raise Issue of Disposal and Risks
The New York Times
December 6, 2012

Drug companies oppose a local California law requiring them to fund and operate a program that allows consumers to dispose of unused prescription medications.

Read more:
http://www.nytimes.com/2012/12/07/business/drug-makers-challenge-pill-disposal-law-in-california.html?_r=0&adxnnl=1&ref=us&adxnnlx=1354885596-zvidCttRoFM069F5R9K2Ag


Heroin Deaths Rise as Crackdown on Prescription Drug Abuse Succeeds
The Baltimore Sun
December 7, 2012

The Maryland Department of Health and Mental Hygiene recorded 205 heroin-related overdose deaths in the first 7 months of 2012 (145 were documented during the same period in 2011). In comparison, overdose deaths related to prescription opioids such as oxycodone, hydrocodone, and methadone declined by 15 percent, from 208 to 177.

Read more:
http://www.baltimoresun.com/health/bs-md-heroin-overdoses-20121207,0,4012683.story


Opioid Overdose Treatment and Prevention: Often Overlooked at Community Level
The Partnership at Drugfree.org
December 7, 2012

Although many prescription drug abuse programs concentrate on ending medication diversion, an often overlooked but critical issue is the prevention and treatment of opioid overdoses, according to a Brown University researcher.

Read more:
http://www.drugfree.org/join-together/prescription-drugs/opioid-overdose-treatment-and-prevention-often-overlooked-at-community-level


A New Prescription to Treat Prescription Drug Abuse
SmartPlanet.com
December 3, 2012

Clinical trials are now under way to measure the efficacy of MediciNova's Ibudilast--a treatment for dependency on drugs such as OxyContin, Percocet, and Vicodin. Ibudilast is expected to aid addiction treatment because it crosses the blood-brain barrier and restores normal "glial cell" activity, which could reduce intense opioid cravings.

Read more:
http://www.smartplanet.com/blog/bulletin/a-new-prescription-to-treat-prescription-drug-abuse/7251


Minnesota Tribes See Prescription Drug Use Leading to Heroin Addiction
Indian Country Today
December 6, 2012

The White Earth and Red Lake nations have declared public health emergencies related to prescription drug abuse. In 2011, prescription drugs were involved in 14.4 percent of drug arrests--up from 4.5 percent in 2004. According to the 2012 Drug and Violent Crime Task Forces, the average Minnesota heroin user is 16-28 years old and has turned to the drug after becoming addicted to prescription painkillers.

Read more:
http://indiancountrytodaymedianetwork.com/opinion/minnesota-tribes-see-prescription-drug-use-leading-heroin-addiction-146151


Report and Fact Sheet

Ensuring Safe and Appropriate Prescription Painkiller Use: The Important Role of Community Health Plans
Alliance of Community Health Plans
November 2012

This report discusses the important role of community health plans.

Read more:
https://s3.amazonaws.com/achp_downloads_wordpress/downloads/2012/11/ACHP%20Brief%20-%20Ensuring%20Safe%20and%20Appropriate%20Prescription%20Painkiller%20Use.pdf
Related Fact Sheet
Key Points: Ensuring Safe and Appropriate Prescription Painkiller Use
Alliance of Community Health Plans
2012

Read this one-page fact sheet on opioid misuse and health plans.

Read more:
https://s3.amazonaws.com/achp_downloads_wordpress/downloads/2012/11/Key%20Points%20-%20Ensuring%20Safe%20and%20Appropriate%20Prescription%20Painkiller%20Use.pdf 

Additional Resource

Corporations: Find Employee Outreach Resources
AWARERx.org
Accessed December 3, 2012

AWARERx is a consumer protection program created by the National Association of Boards of Pharmacy Foundation. It provides corporations with resources for educating employees about safe medication use, prescription drug abuse dangers, and how to safely order medication online.

Read more:
http://www.awarerx.org/corporations


Course

Abuse of Prescription Stimulant Drugs: Continuing Pharmacy Education Module (fee required)
Dextroamphetamine/amphetamine combination (Adderall), methylphenidate (Concerta), and lisdexamfetamine (Vyvanse)--Schedule II medications--are the drugs most commonly prescribed to children and adults with attention deficit hyperactivity disorder (ADHD). Although these drugs are very effective for ADHD treatment, there is also the potential for abuse and addiction.

Target audience: Pharmacists
Program length: 1 hour (0.1 CEU)
Administered by Ohio Northern University

Read more:
http://www.onu.edu/node/45009
 
 
Please e-mail Rekaya Gibson at rgibson@pire.org with questions or comments about the SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv.  
 
 
 About PAW and the Listserv
The PAW TA Center addresses prescription drug abuse--a growing public health problem with increasing burdens on workers, workplaces, and our economy. Prescription drug abuse affects workplace productivity and increases employee absenteeism, employee presenteeism, and workers' compensation claims. On a wider scale, overdose deaths linked to prescription opioids tripled from 1999 to 2006, and prescription drug abuse killed more Americans in 2009 than died that year in auto crashes.
 
Send your request for PAW technical assistance to PAW-TA@pire.org or contact Rekaya Gibson at 504.261.8107 or Deborah Galvin at 240.276.2721. Requests are subject to SAMHSA approval. You will be notified of the status of your request.
 
We aim to conduct systematic and inclusive searches of professional journals, leading newspapers and magazines, and federal websites, as well as contributions from listserv subscribers (please e-mail suggestions to rgibson@pire.org). We will send links to articles along with brief descriptions of those articles. As we develop the listserv, however, we hope to add commentary and invite feedback from subscribers. Our goal is to expand the listserv to become a widely used and recognized source of the most current and authoritative information on prescription drug abuse--especially in workplaces.
 
The "SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv" is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoints or opinions and are not assessed for validity, reliability, or quality. The "SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv" should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full-text journal articles. 
 
Return to Listserv Archive Home